Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab

Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab

Despite being extremely rare, Guillain-Barré syndrome (GBS) has been recognized as a neurological complication of multiple myeloma, with variable responses to plasmapheresis (PEX), intravenous immunoglobulins (IVIG), and anti-myeloma therapies. In this paper, we report a case of a female patient...

Full description

Bibliographic Details
Main Authors: Ivan Krečak, Velka Gverić-Krečak
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2023-01-01
Series:Acta Clinica Croatica
Subjects:
Guillain-Barré syndrome
Rituximab
Monoclonal immunoglobulin
Multiple myeloma
Online Access:https://hrcak.srce.hr/file/445803

Similar Items

Similar Items